Skip to content
Revisional Bariatric Surgery · IFSO Position Statement 2020

Revision Bariatric Surgery in Turkey — Re-Sleeve, Sleeve-to-Bypass & Sleeve-to-DS at Eyeglow Istanbul

Revisional bariatric surgery for patients with weight regain, intractable GERD, or sleeve dilation after primary sleeve gastrectomy. Options: re-sleeve (anatomical reset), Sleeve-to-RYGB conversion (GERD + regain), Sleeve-to-DS (super-obese), and endoscopic OverStitch (less invasive, lower efficacy). Complication rate 2–3× primary. Leak rate 2–5%. Mandatory pre-op workup. Expected EWL 30–50% from revision — lower than primary. Honest pre-operative assessment is the determinant of revision success. Partner bariatric surgeon team.

Revision sleeve gastrectomy at Eyeglow, Istanbul
Revision typeRe-sleeve · Sleeve→RYGB · Sleeve→DS · Endoscopic OverStitch
AnaesthesiaGeneral
Complication rate2–3× higher than primary bariatric
Hospital stay8–10 days
Expected weight loss30–50% EWL (lower than primary)
Leak rate2–5% (vs 1–2% primary)
What it is

What is revision bariatric surgery?

Revision bariatric surgery covers all procedures performed to correct, convert, or supplement a prior bariatric operation that has not achieved or maintained its intended outcome. For patients with a prior sleeve gastrectomy, three main surgical revision options exist: re-sleeve (anatomical re-tubularisation), Sleeve-to-RYGB conversion (the most common — adds malabsorption and gut hormone enhancement, and reliably improves post-sleeve GERD), and Sleeve-to-DS conversion (highest weight loss, highest nutritional risk). An endoscopic non-surgical option (OverStitch plication) is available for selected patients who prefer to avoid surgery.

At Eyeglow Health, revisional bariatric surgery is coordinated through our accredited partner bariatric surgeon team at an accredited hospital in Istanbul. Eyeglow Health is an eye-care specialist clinic — bariatric and revisional surgical procedures are delivered by the partner team. Both Eyeglow and the partner hospital hold the Turkish Ministry of Health International Health Tourism Authority Certificate. We follow IFSO Position Statement on Revisional Surgery (2020) and ASMBS Position Statement on Sleeve Gastrectomy Outcomes for candidacy criteria, mandatory pre-operative workup, and post-operative monitoring.

Revision surgery is not an "easy fix." Complication rates are 2–3× higher than primary bariatric surgery. Expected weight loss from revision is 30–50% EWL — lower than primary surgery in all categories. The mandatory pre-operative workup exists to identify failure mechanism and correct modifiable risks before proceeding. Patients who approach revision without this assessment are at higher risk of both surgical complications and repeated failure.

How it works

From failure mode analysis to 12-month post-revision follow-up

  1. 01

    Revision candidacy assessment — failure mode analysis

    Understanding why your primary procedure did not achieve or maintain its outcome is the essential starting point. You share your original bariatric procedure, date of surgery, peak weight loss achieved, current weight, timeline of regain, current symptoms (reflux severity, GERD grade, eating behaviour), current medications, and any prior abdominal or revisional surgery. The bariatric surgeon reviews the IFSO Position Statement on Revisional Surgery (2020) criteria: revision is indicated for weight regain with >25% EWL loss from nadir, intractable GERD post-sleeve (particularly where Barrett's metaplasia is a risk or has been confirmed), inadequate initial weight loss (<50% EWL at 18 months), or progressive sleeve dilation. Revision without a clear anatomical or behavioural failure diagnosis is not appropriate — a revision performed on an adequately functioning sleeve with poor dietary compliance will fail for the same reason the primary failed.

  2. 02

    Mandatory pre-operative workup — endoscopy + upper GI series + EWL calculation

    Pre-operative workup for revision is more extensive than for primary bariatric surgery and is non-negotiable. Upper-GI endoscopy: assesses current sleeve anatomy (dilation, fundal dilation, gastro-oesophageal junction competence, GERD grade, presence of Barrett's metaplasia, H. pylori status, stomal diameter, absence of ulcer or stricture). Upper GI contrast series (barium swallow): documents sleeve tube diameter, length, and emptying dynamics. Sleeve dilation is confirmed by comparing current anatomy to typical post-primary dimensions. Body composition analysis and EWL calculation establish the degree of weight regain and set the revision weight-loss target. Psychological assessment is routine — behavioural re-engagement and realistic expectations must be confirmed before proceeding. Full blood panel including nutritional status (B12, iron, vitamin D, calcium, zinc, protein/albumin) — nutritional deficiency must be corrected before revision.

  3. 03

    Revision procedure selection — anatomical + clinical rationale

    Revision procedure is selected based on the failure mode confirmed by pre-op workup. Sleeve→RYGB conversion (most common revision): indicated primarily for intractable GERD (bypass improves reflux while sleeve worsens it) combined with weight regain, or for inadequate metabolic response (T2DM persistence). The gastric pouch is fashioned from the existing sleeve tube. RYGB adds malabsorption and gut hormone enhancement. Re-sleeve (sleeve tubularisation): indicated for anatomically confirmed sleeve dilation without GERD — the dilated fundus or body is re-stapled. The existing staple line must be technically suitable for re-stapling without compromising blood supply. Sleeve→DS conversion: indicated for super-obese revision (BMI remains >50 after primary) requiring maximum weight loss; adds biliopancreatic diversion to the existing sleeve. Highest efficacy, highest nutritional deficiency risk. Endoscopic Re-Sleeve OverStitch (Apollo/Boston Scientific): non-surgical endoscopic plication of dilated sleeve tissue to reduce lumen diameter. Less invasive than surgical revision, lower efficacy, not suitable for GERD indication.

  4. 04

    Laparoscopic revision surgery (120–180 minutes typical)

    Revision surgery is technically more demanding than primary bariatric surgery because of adhesions (scar tissue from the primary procedure), altered tissue planes, and the need to work around an existing staple line. Typical operative time: Sleeve→RYGB 120–150 minutes; re-sleeve 90–120 minutes; Sleeve→DS 150–180 minutes. Under general anaesthesia, laparoscopic access is achieved carefully given intra-abdominal adhesions. Adhesiolysis (adhesion division) is performed before the revision anatomy can be established. For Sleeve→RYGB: the existing sleeve is divided proximally to create a 30 ml pouch; the small bowel is rerouted in Roux-en-Y configuration. For re-sleeve: the dilated gastric body and/or fundus is excised along a new calibrated bougie. Intraoperative leak test and blood supply assessment are performed before closure. Drain placement is standard (higher leak risk).

  5. 05

    Hospital recovery — 8–10 days

    Revision surgery requires longer hospital observation than primary bariatric because complication risk is higher. Post-operative contrast study (upper GI, day 2–3) is mandatory before advancing diet. Drain output is monitored carefully — drain amylase testing if leak is suspected. Clear liquid diet in hospital, advancing to full liquids at day 5–7 if contrast study is clear. Nutritional support (protein supplements, IV thiamine) begins immediately given the nutritional risk that accumulates from the primary procedure plus revision. DVT prophylaxis is continued throughout hospital stay and 4 weeks post-discharge. Discharge occurs only when oral fluid tolerance is confirmed, pain is controlled, and contrast study is clear.

  6. 06

    Post-operative lifestyle re-engagement — the critical phase

    Revision surgery does not automatically reverse the dietary behaviours that contributed to primary failure. The post-revision period requires active dietitian re-engagement: staged diet progression (clear liquids → full liquids → purée → soft → solid), protein prioritisation (minimum 60–80g/day), eating speed correction, portion control, and elimination of grazing behaviour. Psychological support is recommended for patients who identify emotional eating, food addiction patterns, or disordered eating as contributors to regain. Weight loss is typically most rapid in months 1–6 post-revision, continues to month 12, plateau by month 18. Expected EWL from revision: 30–50% — lower than primary surgery in all categories. Patients must understand this before consenting — revision is not a reset to primary-surgery outcomes.

  7. 07

    12-month structured follow-up + nutritional monitoring

    Scheduled video reviews at 1, 3, 6 and 12 months. Nutritional bloods at each visit: B12, iron, calcium, vitamin D, zinc, protein, albumin, HbA1c (if T2DM present). After Sleeve→DS revision, fat-soluble vitamin panel (A, D, E, K) is added — water-soluble supplementation forms required. After Sleeve→RYGB, the standard RYGB nutritional protocol applies: daily multivitamin, B12, calcium citrate, vitamin D, iron. Weight loss curve monitoring and EWL calculation at each visit. Bariatric coordinator is available 24/7 for concerns during recovery. A frank discussion of whether weight loss targets are being achieved occurs at 6-month review — if not, behavioural audit is conducted before considering any further intervention.

Revision options

Re-sleeve vs Sleeve-to-RYGB vs Sleeve-to-DS vs Endoscopic OverStitch

All four revision approaches address the primary anatomical or metabolic indication, with meaningfully different risk profiles, efficacy, and indications:

AspectRe-sleeveSleeve→RYGBSleeve→DSEndoscopic OverStitch
MechanismAnatomical reset — re-tubularisation of dilated sleeveRestriction + malabsorption + gut hormone (GLP-1/GIP) enhancementMaximum malabsorption + restrictionEndoscopic plication — reduces sleeve lumen non-surgically
Primary indicationSleeve dilation without significant GERDIntractable GERD + weight regain; metabolic T2DM persistenceSuper-obese revision (BMI >50 after primary)Mild-moderate sleeve dilation, surgery-averse patients
Expected EWL from revision30–40%35–50%40–55%15–25% (lowest efficacy)
GERD effectNeutral to slight improvement (not indicated for severe GERD)Significantly improves GERD — preferred for GERD indicationVariable — not the preferred GERD solutionNo benefit for GERD
Complication rate vs primary2× higher (adhesions, re-stapling)2–3× higher (complex anatomy, new anastomosis)3× higher (highest complexity)Substantially lower than surgical revision
Leak rate2–4%2–5%3–6%<1%
Nutritional riskModerate (similar to primary sleeve)Moderate-high (RYGB protocol + prior sleeve deficiencies)High — DS-level fat-soluble vitamin + protein deficiencyLow
Hospital stay5–7 nights7–10 nights8–10 nights0–1 night
Pricing

Personalised pricing

Every treatment plan is priced individually after your consultation. Request a written, all-inclusive quote — clear, itemised, and with no obligation.

Request a written quote
Package transparency

What's included in your revision bariatric surgery package

Included in package

  • Pre-operative revision candidacy assessment — failure mode analysis
  • Upper-GI endoscopy + contrast swallow series + EWL calculation
  • Psychological assessment (behavioural re-engagement and realistic expectations)
  • Full blood panel including comprehensive nutritional status (B12, iron, D, calcium, zinc, albumin, protein)
  • Bariatric surgeon consultation + IFSO revisional surgery eligibility review + informed consent
  • Revision surgery at partner accredited hospital (re-sleeve, Sleeve→RYGB, or Sleeve→DS)
  • General anaesthesia + intraoperative adhesiolysis + leak test
  • Intraoperative drain placement (standard for revision)
  • Hospital stay — 8–10 nights private room (procedure-dependent)
  • 5-star hotel — 2–3 nights post-discharge
  • VIP airport transfers + hospital-hotel transfers
  • Post-op upper-GI contrast study (mandatory before diet advancement)
  • All post-op medications: PPI, DVT prophylaxis 4 weeks, analgesia, anti-emetics
  • Nutritional supplementation initiation and prescription guidance at discharge
  • 1, 3, 6 and 12-month video follow-up + nutritional bloods interpretation
  • Multilingual bariatric coordinator — 24/7 throughout stay
  • Complication insurance policy (Türkiye Ministry of Health certified, covers surgical complications including infection, retreatment, and emergency intervention up to package value)

Paid separately

Items below are not part of the medical package — your coordinator helps you arrange them at no markup.

  • Flights to/from Istanbul
  • Personal expenses and food after discharge
  • Lifelong nutritional supplements (multivitamin, B12, calcium citrate + vitamin D, iron — non-optional, prescribed at discharge; DS-level supplements additionally required for Sleeve→DS)
  • Ongoing psychological or dietitian support beyond the 12-month programme
  • Plastic surgery for post-weight-loss skin laxity (quoted separately)
  • Travel insurance (recommended — covers flight cancellation, baggage, non-surgical medical emergencies abroad; we coordinate referral if needed)
Candidacy

Are you a candidate for revision bariatric surgery?

You may be a revision candidate if

  • You have confirmed weight regain of >25% of your primary EWL loss, documented at nadir (lowest weight achieved) versus current weight, per IFSO Revisional Surgery Position Statement (2020) criteria.
  • You have intractable GERD post-sleeve — persistent severe reflux despite proton-pump inhibitor therapy, confirmed by endoscopy and GERD symptom scoring, particularly if Barrett's metaplasia has been identified or is at risk.
  • Your upper-GI endoscopy and contrast swallow series confirm anatomical sleeve dilation (fundal dilation or tubular dilation) as a contributor to weight regain — not purely dietary non-compliance.
  • You have persistent or worsening T2DM after primary sleeve gastrectomy and sleeve-to-bypass conversion offers superior metabolic benefit for your specific profile.
  • You understand that revision surgery complication rates are 2–3× higher than primary bariatric, expected weight loss from revision is 30–50% EWL (lower than primary), and that lifestyle re-engagement is the determinant of durable outcome — not the procedure alone.

Revision is not indicated if

  • Your sleeve anatomy is intact and functioning — weight regain is purely related to dietary non-compliance, grazing behaviour, or return to poor eating habits without anatomical explanation. Revision on a functioning sleeve does not override behaviour.
  • You have not undergone structured psychological assessment and dietary audit — revision without understanding the primary failure mechanism is unlikely to produce a different result.
  • Your nutritional status (B12, iron, vitamin D, calcium, protein) has not been evaluated and corrected pre-operatively — proceeding with revision surgery with active nutritional deficiency significantly increases risk.
  • You are seeking revision less than 18 months from primary surgery — weight loss trajectory after primary surgery continues to 18 months; early assessment of "failure" before this plateau is not clinically appropriate.
  • You have active untreated psychiatric condition, uncontrolled eating disorder, or active substance use — these require stabilisation before any bariatric revision.

Disclaimer. Information on this page is consistent with IFSO Position Statement on Revisional Surgery (2020), ASMBS Position Statement on Sleeve Gastrectomy Outcomes, and Turkish Ministry of Health International Health Tourism Authority Certificate requirements. Complication rates, leak rates, and expected weight-loss data are from published peer-reviewed sources — not marketing claims. Revision surgery requires a higher standard of pre-operative assessment than primary bariatric — mandatory pre-op workup (endoscopy, contrast swallow, psychological assessment, nutritional panel) is non-negotiable per IFSO standards. This is educational information — not a substitute for individualised assessment by a bariatric surgeon experienced in revisional procedures.

Risks & outcomes

Realistic outcomes — the risks that actually matter in revision surgery

Revision bariatric surgery has a meaningfully different risk profile from primary bariatric surgery. We present these risks with the same directness our partner bariatric surgeon uses at consultation:

Complication rate 2–3× higher than primary bariatric surgery

This is the central honest fact about revisional bariatric surgery. Per IFSO Position Statement on Revisional Surgery (2020) and ASMBS Position Statement on Sleeve Gastrectomy Outcomes, all major operative and post-operative complication rates are approximately 2–3× higher than equivalent primary procedures. Reasons include: intra-abdominal adhesions from the primary surgery increasing technical difficulty and risk of inadvertent enterotomy (bowel injury), altered tissue planes making haemostasis harder, existing staple line requiring careful management during re-dissection, and the possibility of compromised tissue blood supply in the revision field. Patients considering revision must be explicitly counselled that the safety profile is materially different from what they experienced with their primary procedure.

Anastomotic and staple-line leak rate 2–5%

Leak rate after revision bariatric surgery is approximately 2–5%, compared to 0.5–1% for primary sleeve gastrectomy and 1–3% for primary RYGB. For Sleeve→RYGB conversion, the new gastrojejunal anastomosis is formed in tissue that has been dissected, stapled, and mobilised previously — healing may be less reliable than in virgin tissue. For re-sleeve, re-stapling adjacent to an existing staple line carries risk of ischaemia at the staple line margin. Post-operative contrast study (upper-GI) before diet advancement is mandatory — not optional. Drain output is monitored throughout hospital stay. Patients are briefed on warning signs (fever, tachycardia, shoulder pain, abdominal pain) and have 24/7 coordinator access. Late leaks require prompt CT imaging and intervention.

Lower expected weight loss than primary surgery (30–50% EWL)

Revision surgery does not produce primary-surgery-equivalent weight loss. Published IFSO and ASMBS revisional data consistently show EWL from revision of 30–50%, compared to 60–70% for primary sleeve and 70–80% for primary RYGB. Multiple factors contribute: the remaining stomach tissue has adapted to restriction; the patient's metabolic set-point may have adjusted; the surgery is being performed on a system that has already undergone anatomical modification; and the same behavioural factors that contributed to primary failure are present unless specifically addressed. We tell patients this clearly before they consent — revision is not a "second chance at 70% EWL." It is a meaningful clinical intervention for specific anatomical and metabolic indications, with realistic expected outcomes that are lower than primary.

"Easy fix" mindset — the primary predictor of revision failure

The single most important risk factor for revision failure is proceeding without addressing the primary failure mechanism. If the primary sleeve failed due to dietary non-compliance, grazing, emotional eating, or inadequate lifestyle engagement — and these behaviours are not assessed and modified before revision — the revision will fail for the same reasons. IFSO revisional guidelines explicitly require psychological assessment and behavioural audit as part of the pre-operative workup. Patients who approach revision as a surgical correction to a behavioural problem will, statistically, regain weight after revision. Our pre-operative assessment is designed to identify this risk honestly — not to disqualify patients, but to ensure that revision is accompanied by genuine lifestyle re-engagement.

Nutritional deficiency compounded from primary procedure

Patients presenting for revision surgery typically have some degree of nutritional deficiency from their primary procedure — B12, iron, vitamin D, and calcium deficiencies are common at the time of revision presentation. Proceeding with surgery in a nutritionally depleted state increases anaesthetic risk, wound healing impairment, and recovery difficulty. Nutritional correction before revision is mandatory. After Sleeve→RYGB revision, RYGB nutritional monitoring protocols apply. After Sleeve→DS revision, DS-level monitoring is required — fat-soluble vitamins in water-soluble form, protein minimum 80g/day, comprehensive annual bloods. Patients who have already been non-compliant with primary sleeve nutritional monitoring face a more intensive monitoring requirement after revision.

FAQ

Frequently asked questions about revision bariatric surgery in Turkey

Is revision bariatric surgery riskier than primary bariatric surgery?

Yes — and we are direct about this because it is the most important fact for a revision candidate to understand. Revision bariatric surgery complication rates are approximately 2–3× higher than equivalent primary procedures, per IFSO Position Statement on Revisional Surgery (2020). The reasons are anatomical: intra-abdominal adhesions from the primary procedure increase technical complexity; existing staple lines require careful dissection; tissue planes are altered; blood supply may be less reliable in previously operated fields. Anastomotic or staple-line leak rates for revision are 2–5%, compared to 0.5–1% for primary sleeve gastrectomy. This is not a reason to avoid revision when it is clinically indicated — the clinical justification for revision (intractable GERD, significant weight regain, sleeve dilation) must be weighed against the higher procedural risk. A bariatric surgeon experienced in revisional surgery is essential — revision is not the same operation as primary bariatric.

Why did my gastric sleeve fail?

Sleeve failure is multi-factorial, and honest attribution matters before planning revision. Documented anatomical failure mechanisms include: sleeve dilation (the tubular sleeve gradually expands over 2–5 years, particularly at the fundus if initial calibration was inadequate), hiatus hernia development or worsening (disrupting the high-pressure zone), and stomal incompetence. Physiological failure: ghrelin reduction — the primary appetite-suppression mechanism of sleeve — attenuates over 2–5 years in many patients as residual fundal tissue adapts. Behavioural failure: dietary pattern drift, return to processed foods, grazing behaviour, and reduced physical activity are the most common contributors to weight regain and are the factors most predictive of revision outcome. Distinguishing anatomical failure from behavioural failure is the purpose of the pre-revision workup (endoscopy + contrast swallow + psychological assessment). A revision performed on an anatomically intact functioning sleeve with a behavioural contribution to regain will not produce a different long-term result unless behaviour is also revised.

What is sleeve-to-bypass (RYGB) conversion and who is it for?

Sleeve-to-RYGB conversion is the most commonly performed revisional bariatric procedure. It involves fashioning a small gastric pouch from the proximal portion of the existing sleeve tube, then connecting the pouch to a rerouted segment of small bowel in a Roux-en-Y configuration — adding restriction, malabsorption, and gut hormone enhancement to the residual sleeve restriction. Primary indications: intractable GERD post-sleeve (RYGB reliably improves reflux while sleeve maintenance often worsens it, and GERD after sleeve is associated with Barrett's metaplasia risk — a pre-cancerous change requiring surveillance and treatment), combined with weight regain. Secondary indication: inadequate T2DM remission after primary sleeve, where bypass offers superior metabolic pathway activation. The conversion is technically more demanding than primary RYGB and carries a higher leak and anastomotic complication rate. Patients with GERD as the primary indication have the strongest evidence base for conversion benefit.

What is a re-sleeve and when is it appropriate?

Re-sleeve (sleeve tubularisation or re-calibration) is the surgical revision of a dilated gastric sleeve by resecting the expanded fundal or body portion and re-creating a tighter tubular sleeve. It is appropriate when: upper-GI endoscopy and contrast swallow confirm anatomical sleeve dilation as the primary mechanism of weight regain; GERD is absent or mild (re-sleeve is not the appropriate procedure for GERD — that requires conversion to RYGB); and the existing staple line is technically suitable for re-stapling without compromising blood supply. Re-sleeve has a simpler technical profile than Sleeve→RYGB but requires careful assessment of whether the sleeve dilation is the actual cause of regain (versus behavioural drift) — re-sleeve on a behaviourally-failing patient produces the same inadequate result. Expected EWL from re-sleeve: 30–40%, lower than Sleeve→RYGB conversion.

What is GERD after gastric sleeve, and why is it a concern?

GERD (gastro-oesophageal reflux disease) is a documented complication of sleeve gastrectomy, occurring as new-onset GERD in 10–20% of sleeve patients at 5 years and worsening in patients with pre-existing reflux. The mechanism: the high-pressure narrow tubular sleeve increases intra-gastric pressure, particularly when the lower oesophageal sphincter is compromised. Persistent, severe GERD after sleeve is clinically important for two reasons: (1) persistent mucosal acid exposure causes chronic oesophagitis, which over years can lead to Barrett's metaplasia (replacement of normal oesophageal squamous epithelium with intestinal columnar epithelium) — a recognised precursor of oesophageal adenocarcinoma; (2) quality of life impact is substantial. Sleeve-to-RYGB conversion is the evidence-supported treatment for intractable post-sleeve GERD — bypass anatomy diverts acid away from the oesophagus. Patients with confirmed Barrett's metaplasia require endoscopic surveillance per local gastroenterology guidelines.

How long after my primary sleeve should I wait before considering revision?

IFSO revisional guidelines recommend that the primary weight-loss curve be allowed to complete before revision is assessed. Primary sleeve gastrectomy weight loss typically continues to month 18 — significant weight regain before this point does not constitute a "failed sleeve" by IFSO criteria, and premature revision surgery carries higher risk without proven benefit. The appropriate timing for revision assessment: weight regain >25% EWL from nadir after at least 18 months post-primary, confirmed by documented weight history. GERD as an indication is different — worsening GERD with endoscopic evidence may justify earlier conversion if medically necessary. The pre-revision workup requires weight history documentation going back to primary surgery — your surgical and medical records are needed before revision can be appropriately assessed.

Can revision bariatric surgery be done laparoscopically?

Yes — the majority of revision bariatric procedures are performed laparoscopically, including Sleeve→RYGB conversion, re-sleeve, and Sleeve→DS. The laparoscopic approach requires greater technical skill for revision than for primary surgery because of adhesions and altered anatomy, and operating time is typically longer. In a small percentage of cases, dense adhesions or intraoperative findings require conversion from laparoscopic to open surgery — this is discussed at consent as an unlikely but possible outcome. The benefits of laparoscopic revision (shorter hospital stay, lower infection risk, faster recovery) are maintained in experienced hands. The partner bariatric surgeon team at Eyeglow Health has documented experience in laparoscopic revisional bariatric procedures; surgeon volume matters more for revision than for primary surgery.

What is endoscopic revision (OverStitch) and who is it for?

Endoscopic sleeve revision using suturing devices (OverStitch, Apollo Endosurgery; or USGI Medical's Primary Obesity Surgery Endoluminal / POSE system) uses endoscopically placed sutures or plications to reduce the lumen diameter of a dilated gastric sleeve without surgery. No incisions, no general anaesthesia required in most cases. It is the least invasive revision option and carries a substantially lower complication profile. Limitations: (1) efficacy is lower than surgical revision — expected EWL of 15–25%, compared to 35–50% for Sleeve→RYGB; (2) it does not address GERD — endoscopic revision has no benefit for the reflux indication; (3) durability data beyond 2 years are limited; (4) repeat procedures may be required. Appropriate candidates: mild-moderate sleeve dilation without GERD indication, patients who are not surgical candidates due to comorbidity, patients who prefer a non-surgical approach and accept lower expected weight loss.

What lifestyle changes are required after revision surgery?

The same rules as primary bariatric — but with greater accountability because the revision is a second resource spent on the same problem. Five permanent changes: (1) protein priority — 60–80g/day minimum, at every meal, before other macronutrients; (2) portion discipline — the revised stomach capacity is limited and consistent overfilling delays healing and promotes pouch dilation; (3) no grazing — three structured meals, no continuous low-volume eating (this is the most common post-revision failure behaviour); (4) lifelong nutritional supplementation per procedure protocol (multivitamin, B12, calcium citrate, vitamin D, iron; additional fat-soluble vitamins for DS); (5) structured follow-up — 12-month programme is included, ongoing annual bloods are expected indefinitely. Our pre-revision psychological assessment specifically addresses eating patterns that contributed to primary failure — the post-revision dietitian engagement is designed to target these patterns, not just repeat the post-primary protocol.

How much weight can I expect to lose with revision surgery?

Published data from IFSO and ASMBS revisional programme analyses consistently show EWL from revisional bariatric surgery of 30–50%, lower than primary bariatric outcomes (60–70% for sleeve, 70–80% for RYGB). Sleeve→RYGB conversion typically achieves 35–50% EWL from revision. Re-sleeve: 30–40% EWL from revision. Sleeve→DS: 40–55% EWL from revision. Endoscopic OverStitch: 15–25%. These figures are from the revision point — they represent additional weight loss on top of what was retained from the primary procedure. Patients who regained all primary-surgery weight and approach revision at their pre-surgery weight should calculate realistic final weight using these revision-specific figures, not primary-surgery figures. We present this calculation honestly at consultation — a patient at 130 kg who lost 30 kg and regained 25 kg (net loss 5 kg) undergoing revision has a realistic target of an additional 20–30 kg loss from revision, not a return to peak primary-surgery results.

How does sleeve-to-DS conversion differ from sleeve-to-RYGB for super-obese patients?

For patients with BMI remaining above 50 after primary sleeve gastrectomy despite lifestyle engagement, Sleeve→DS (Duodenal Switch) conversion adds biliopancreatic diversion to the existing sleeve — creating severe caloric and fat malabsorption alongside restriction. This produces the highest weight loss of any revisional or primary bariatric procedure (EWL 40–55% from revision) and the highest T2DM remission rates. The trade-off is the most demanding nutritional requirement of any procedure: protein minimum 80g/day, water-soluble fat-soluble vitamins (A, D, E, K) indefinitely, calcium citrate at high dose, zinc, selenium, comprehensive annual nutritional panel. DS conversion is not appropriate for patients who cannot commit to this monitoring or who have limited access to metabolic follow-up care. Sleeve→RYGB, by contrast, carries a more manageable nutritional requirement and is the standard recommendation for non-super-obese revision candidates.

Why is the mandatory pre-op workup so extensive for revision?

Because operating on a patient without understanding why the primary procedure failed, and without correcting modifiable risks, is a significant contributor to revision failure and preventable complications. The pre-revision endoscopy confirms or excludes anatomical failure — sleeve dilation, stomal diameter, GERD grade, Barrett's. The contrast swallow documents functional anatomy. The psychological assessment identifies behavioural patterns. The nutritional panel identifies deficiency that must be corrected before anaesthesia. Without all of these, revision surgery is performed on incomplete information. A surgeon who quotes revision surgery without requiring this workup is not following IFSO standards. We are explicit about this because some patients find the workup burdensome — but it is not optional, and a bariatric surgeon who skips it is not doing you a favour.

Why does Eyeglow coordinate revision surgery through a partner clinic?

Eyeglow Health is an eye-care specialist clinic. All bariatric and revisional surgical procedures — re-sleeve, Sleeve→RYGB, Sleeve→DS, and endoscopic revision — are performed by our partner bariatric surgeon team at an accredited hospital in Istanbul. The partner team holds documented revisional bariatric experience — revision is not the same procedure as primary bariatric surgery and surgeon volume in revisional procedures matters. The partner hospital holds the Turkish Ministry of Health International Health Tourism Authority Certificate. Eyeglow coordinates: multilingual coordinator from inquiry to 12-month follow-up, clinical documentation, complication insurance, transfers, and hotel. We are transparent about this structure because you deserve to know who holds the scalpel. If any aspect of the partner arrangement raises questions, ask us directly before proceeding.
Get a free assessment